• Ionomycin Free Acid: Reliable Calcium Ionophore for Cell Ass

  2026-06-05

  This article addresses laboratory challenges in calcium-dependent cell assays, highlighting how Ionomycin free acid (SKU B6947) enables reproducible and sensitive manipulations of intracellular calcium. Scenario-driven Q&A blocks demonstrate its practical advantages for workflow optimization and data reliability, with evidence-backed recommendations for biomedical researchers.

• E4orf1 Modulates Metabolism and Cognition in Alzheimer’s Mod

  2026-06-05

  The reference study demonstrates that E4orf1, an adenoviral protein, can improve glycemic control, reduce hepatic steatosis, and enhance cognitive performance in a transgenic mouse model of Alzheimer’s disease. These findings suggest a mechanistic bridge between metabolic health and neurodegeneration, providing new directions for research into obesity-linked cognitive decline.

• Betaine-Enhanced LNPs Improve mRNA Delivery After Freezing

  2026-06-04

  A recent study reveals that incorporating betaine into lipid nanoparticles during freeze-thaw cycles significantly improves mRNA delivery efficacy and immune response. This work introduces a new strategy for stabilizing and functionally upgrading mRNA-LNP formulations by leveraging freeze concentration–driven molecular incorporation.

• Polymeric Nanozymes Target Intramacrophage Bacteria for CRC

  2026-06-04

  This study introduces a self-activatable polymeric nanozyme platform designed to precisely eradicate Fusobacterium nucleatum residing within tumor-associated macrophages in colorectal cancer. By combining targeted delivery, reactive oxygen species amplification, and autophagy induction, the approach significantly enhances the efficacy of CD47 blockade immunotherapy.

• Bufalin: Cardiotonics Transforming Triple-Negative Breast Ca

  2026-06-03

  Bufalin, a potent cardiotonic steroid from APExBIO, is emerging as a precision tool for driving apoptosis in aggressive cancer cells by targeting Serine/Threonine Kinase 33. Discover validated workflows, troubleshooting insights, and advanced applications that place Bufalin at the forefront of translational triple-negative breast cancer research.

• 4-Phenylbutyric Acid: Precision ER Stress Inhibition in Neph

  2026-06-03

  Discover how 4-Phenylbutyric acid (4-PBA) enables advanced ER stress alleviation and apoptosis research in kidney toxicity models. Uniquely, this article dissects mechanistic insights and protocol strategies informed by recent breakthroughs.

• Enhanced A40926 Antibiotic Production via Engineered Nonomur

  2026-06-02

  This study reports a substantial increase in the yield of the glycopeptide antibiotic A40926 by engineering Nonomuraea gerenzanensis through targeted genetic modifications and systematic optimization of fermentation media. The findings highlight the synergistic impact of polygenic manipulation and medium design on industrial antibiotic biosynthesis, with implications for improving glycopeptide production for research and clinical development.

• Chloramphenicol in Translational Research: Mechanisms to Str

  2026-06-02

  This thought-leadership article examines chloramphenicol’s mechanistic role as a bacterial protein synthesis inhibitor and its strategic value in translational molecular biology research. Integrating recent multidrug-resistance epidemiology, it offers actionable guidance for experimental design and highlights APExBIO’s high-purity chloramphenicol as a trusted reagent for robust, reproducible workflows.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor in Ca

  2026-06-01

  EPI-001 sets itself apart as a potent androgen receptor N-terminal domain inhibitor, uniquely disrupting both ligand-dependent and ligand-independent AR signaling. Its validated impact in CRPC and TNBC models makes it an essential reagent for researchers targeting transcriptional activity and metastatic pathways.

• Neutrophil Extracellular Traps in CML: Differential Effects

  2026-06-01

  This study demonstrates that neutrophil extracellular trap (NET) formation is significantly increased in chronic myeloid leukemia (CML) and is differentially modulated by distinct tyrosine kinase inhibitors (TKIs). These findings illuminate a potential mechanistic link between TKI therapy, NET-driven vascular toxicity, and disease progression, offering new considerations for translational CML research.

• Live-Dead Cell Staining Kit: Precision in Cell Viability Ass

  2026-05-31

  Unlock robust, dual-fluorescent discrimination of viable and dead cells with the Live-Dead Cell Staining Kit, powered by Calcein-AM and Propidium Iodide. This evidence-based workflow guides you through advanced applications, experimental nuances, and troubleshooting strategies—delivering reproducible results in cytotoxicity and regenerative medicine research.

• Decoding Mucosal Repair: DSS Models and the GPR35-KLF5 Axis

  2026-05-30

  This article offers translational researchers a thought-leadership perspective on leveraging Dextran sulfate sodium salt (MW 35000-45000) to rigorously model colonic barrier disruption and repair. Integrating mechanistic advances—particularly the GPR35-KLF5 circuit in tryptophan metabolism—it provides actionable guidance for optimizing experimental design, interpreting pathophysiological findings, and advancing drug discovery in ulcerative colitis. With direct citation of recent breakthroughs and a critical comparison to established resources, the discussion charts a course for more predictive, mechanistically informed preclinical research.

• HyperScribe Co-transcription Kit Plus: ARCA-Capped mRNA for

  2026-05-29

  Explore how the HyperScribe Co-transcription mRNA Synthesis Kit Plus enables high-fidelity ARCA-capped mRNA synthesis for state-of-the-art nanovaccine development. This article delivers an in-depth analysis of the kit’s molecular advantages and its pivotal role in translational RNA immunotherapy workflows.

• 3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re

  2026-05-29

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis and apoptosis. The mechanistic insights into FOXO3a pathway modulation open new avenues for targeted therapy in drug-resistant colorectal cancer.

• ABCC10 Drives cGAMP Efflux and Radiotherapy Resistance in Ca

  2026-05-28

  Zhang et al. identify ABCC10 as a critical exporter of 2'3'-cGAMP in cancer cells, mediating radiotherapy resistance by suppressing STING-dependent type I interferon signaling. This mechanistic insight highlights new avenues for predicting and overcoming intrinsic tumor radioresistance.

16381 records 1/1093 page Next 12345 下5页 Last page